Tumor Vascular Endothelium: Barrier or Target in Tumor Directed Drug Delivery and Immunotherapy
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 14 (1) , 2-10
- https://doi.org/10.1023/a:1012038930172
Abstract
The therapy of solid tumors with conventional chemotherapeutics, drug delivery preparations and immuno-modulatory agents directed against the tumor cells is corrupted by a major barrier presented by...Keywords
This publication has 55 references indexed in Scilit:
- Endoglin/CD 105 may not be an optimal tumor endothelial treatment targetBreast Cancer Research and Treatment, 1996
- Reduction of EGP‐2‐positive pulmonary metastases by bispecific‐antibody‐redirected T cells in an immunocompetent rat modelInternational Journal of Cancer, 1995
- Problems of Delivery of Monoclonal AntibodiesClinical Pharmacokinetics, 1995
- Targeting of Drugs to the LiverSeminars in Liver Disease, 1995
- Transendothelial transport of modified low-density lipoproteinsAtherosclerosis, 1994
- Cell Adhesion Molecule Expression within the Microvasculature of Human Colorectal MalignanciesClinical Immunology and Immunopathology, 1994
- Gene Therapy and Endothelial Cell Targeting for CancerAnnals of the New York Academy of Sciences, 1994
- How protein hormones reach their target cells. Receptor-mediated transcytosis of hCG through endothelial cells.The Journal of cell biology, 1994
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Endothelial Transcytosis of Iron-Transferrin in the Liver Does Not Involve Endosomal TrafficPathobiology, 1992